Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: CAS:1642-81-5 (
4-(chloromethyl)benzoic acid
)
2
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dihydroxy stilbene derivatives were designed based on lithospermic acid B and were prepared from
4-(chloromethyl)benzoic acid
. The inhibitory activities of the novel compounds against
protein tyrosine phosphatase 1B
(
PTP1B
) were evaluated. 3,4-Dihydroxy stilbene carbonyl compounds (7, 11b, 27b) inhibited
PTP1B
with IC50 values comparable to molybdate, while the conjugation-extended compound (15b) showed inhibition 3-fold better than preclinical RK682. The introduction of electron withdrawing groups or amides into the second phenyl ring, or extension of the conjugation into the stilbene molecule may increase stability of the generated radicals.
...
PMID:Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitors. 1759 44